Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Total Non-Current Liabilities: 2018-2024

Historic Total Non-Current Liabilities for Sunshine Biopharma (SBFM) over the last 4 years, with Dec 2024 value amounting to $744,724.

  • Sunshine Biopharma's Total Non-Current Liabilities rose 30.20% to $636,708 in Q3 2025 from the same period last year, while for Sep 2025 it was $636,708, marking a year-over-year increase of 30.20%. This contributed to the annual value of $744,724 for FY2024, which is 26.70% up from last year.
  • Sunshine Biopharma's Total Non-Current Liabilities amounted to $744,724 in FY2024, which was up 26.70% from $587,764 recorded in FY2023.
  • Over the past 5 years, Sunshine Biopharma's Total Non-Current Liabilities peaked at $744,724 during FY2024, and registered a low of $587,764 during FY2023.
  • Its 3-year average for Total Non-Current Liabilities is $672,584, with a median of $685,264 in 2022.
  • In the last 5 years, Sunshine Biopharma's Total Non-Current Liabilities fell by 14.23% in 2023 and then grew by 26.70% in 2024.
  • Over the past 3 years, Sunshine Biopharma's Total Non-Current Liabilities (Yearly) stood at $685,264 in 2022, then decreased by 14.23% to $587,764 in 2023, then increased by 26.70% to $744,724 in 2024.